v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Series A Convertible Preferred Stock
Preferred Stock
Series B Convertible Preferred Stock
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Beginning Balance at Dec. 31, 2024   $ 3 $ 13 $ 3,095,987 $ (1,046) $ (2,384,552) $ 710,405
Beginning Balance (in Shares) at Dec. 31, 2024 194 2,842,158 305,252,194        
Stock-based compensation expense       37,454     37,454
Common stock issued upon purchase of employee stock purchase plan       669     669
Common stock issued upon purchase of employee stock purchase plan (in shares)     355,708        
Vesting of restricted shares issued for services (in shares)     4,141,748        
Tax payments related to shares retired for vested restricted stock units       (6,148)     (6,148)
Tax payments related to shares retired for vested restricted stock units (in shares)     (1,645,397)        
Common stock issued upon exercise of stock options       15     15
Common stock issued upon exercise of stock options (in shares)     2,586        
Common stock sold in public and/or at the market offering, net of offering costs     $ 1 162,008     162,009
Common stock sold in public and/or at the market offering, net of offering costs (in shares)     32,903,034        
Common stock issued from preferred stock conversion   $ (1)   1      
Common stock issued from preferred stock conversion (in Shares)   (909,491) 909,491        
Unrealized loss on investments         (140)   (140)
Foreign currency cumulative translation adjustment         22,045   22,045
Net Loss           (227,821) (227,821)
Ending Balance at Jun. 30, 2025   $ 2 $ 14 3,289,986 20,859 (2,612,373) 698,488
Ending Balance (in Shares) at Jun. 30, 2025 194 1,932,667 341,919,364        
Beginning Balance at Mar. 31, 2025   $ 2 $ 14 3,262,270 6,294 (2,500,715) 767,865
Beginning Balance (in Shares) at Mar. 31, 2025 194 1,932,667 333,934,387        
Stock-based compensation expense       14,484     14,484
Common stock issued upon purchase of employee stock purchase plan       669     669
Common stock issued upon purchase of employee stock purchase plan (in shares)     355,708        
Vesting of restricted shares issued for services (in shares)     583,120        
Tax payments related to shares retired for vested restricted stock units       (504)     (504)
Tax payments related to shares retired for vested restricted stock units (in shares)     (257,496)        
Common stock sold in public and/or at the market offering, net of offering costs       13,067     13,067
Common stock sold in public and/or at the market offering, net of offering costs (in shares)     7,303,645        
Unrealized loss on investments         (30)   (30)
Foreign currency cumulative translation adjustment         14,595   14,595
Net Loss           (111,658) (111,658)
Ending Balance at Jun. 30, 2025   $ 2 $ 14 3,289,986 20,859 (2,612,373) 698,488
Ending Balance (in Shares) at Jun. 30, 2025 194 1,932,667 341,919,364        
Beginning Balance at Dec. 31, 2025   $ 2 $ 17 3,457,654 16,440 (2,775,530) 698,583
Beginning Balance (in Shares) at Dec. 31, 2025 194 1,932,667 411,938,061        
Stock-based compensation expense       23,561     23,561
Common stock issued upon purchase of employee stock purchase plan       861     861
Common stock issued upon purchase of employee stock purchase plan (in shares)     448,277        
Vesting of restricted shares issued for services (in shares)     2,904,310        
Tax payments related to shares retired for vested restricted stock units       (5,345)     (5,345)
Tax payments related to shares retired for vested restricted stock units (in shares)     (1,247,841)        
Common stock issued upon exercise of stock options       26     26
Common stock issued upon exercise of stock options (in shares)     8,632        
Common stock sold in public and/or at the market offering, net of offering costs     $ 2 148,079     148,081
Common stock sold in public and/or at the market offering, net of offering costs (in shares)     38,919,577        
Unrealized loss on investments         (137)   (137)
Foreign currency cumulative translation adjustment         (3,225)   (3,225)
Net Loss           (126,360) (126,360)
Ending Balance at Jun. 30, 2026   $ 2 $ 19 3,624,836 13,078 (2,901,890) 736,045
Ending Balance (in Shares) at Jun. 30, 2026 194 1,932,667 452,971,016        
Beginning Balance at Mar. 31, 2026   $ 2 $ 18 3,563,659 12,650 (2,854,575) 721,754
Beginning Balance (in Shares) at Mar. 31, 2026 194 1,932,667 438,106,537        
Stock-based compensation expense       11,890     11,890
Common stock issued upon purchase of employee stock purchase plan       861     861
Common stock issued upon purchase of employee stock purchase plan (in shares)     448,277        
Vesting of restricted shares issued for services (in shares)     691,716        
Tax payments related to shares retired for vested restricted stock units       (1,166)     (1,166)
Tax payments related to shares retired for vested restricted stock units (in shares)     (284,889)        
Common stock issued upon exercise of stock options       26     26
Common stock issued upon exercise of stock options (in shares)     8,632        
Common stock sold in public and/or at the market offering, net of offering costs     $ 1 49,566     49,567
Common stock sold in public and/or at the market offering, net of offering costs (in shares)     14,000,743        
Unrealized loss on investments         (52)   (52)
Foreign currency cumulative translation adjustment         480   480
Net Loss           (47,315) (47,315)
Ending Balance at Jun. 30, 2026   $ 2 $ 19 $ 3,624,836 $ 13,078 $ (2,901,890) $ 736,045
Ending Balance (in Shares) at Jun. 30, 2026 194 1,932,667 452,971,016